Close
ACHEMA MIDDLE EAST 2026

CDMO-Biotech Ties Help Cut Business Risk In Drug Development

Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high...

Drug Delivery Via Drones – Get Ready For Exciting Times Ahead

The healthcare industry is experiencing prominent changes because of the rapid advancement of tech. Artificial intelligence- AI is already playing a pivotal role in...

APAC Pandemic Readiness – A Workforce Training Efforts Goal

The Ministry of Health and Welfare in South Korea has gone on to announce a collaborative effort with the Asian Development Bank to carry...

New MHRA Regulation Revamps Lowest-Risk UK Clinical Trials

The Medicines and Healthcare products Regulatory Agency has gone on to launch a new scheme that seeks to lessen the nod time when it comes to...

Alternative Tools For Facility Assessments Provided By FDA

The US FDA has gone on to release a draft guidance that outlines its approach to utilising alternative methods so as to evaluate drug...

EU Pharma Reforms Need Revisions – Swedish Stakeholders

The Swedish government this summer has gone on to provide an opportunity for more than 120 stakeholders so as to share their viewpoints on...

Why Pharmaceutical Packaging Needs a complete overhaul?

Companies within the pharma industry are starting to take notice of several exciting innovations. Be it artificial intelligence, blockchain, or automation, all have the...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...